).
There was no difference in phlebitis rates, when
mechanochemical ablation was compared with EVLA
in the LAMA trial occurring in 7% (5/69) after EVLA
compared with 13% (9/69) after MOCA (P Â¼ .262).170 In
a retrospective trial with 979 limbs, Obi et al171 found,
not surprisingly, more asympt